90 related articles for article (PubMed ID: 2140318)
1. Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
Rudzite VK; Vitols AV; Liepinja DJ; Silava AK
Cor Vasa; 1990; 32(1):56-63. PubMed ID: 2140318
[TBL] [Abstract][Full Text] [Related]
2. The development of coronary insufficiency during prolonged treatment of essential hypertension.
Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic resistance of forearm vessels during prolonged drug treatment of essential hypertension.
Vitols AV; Skarda IJ; Liepinia DJ; Voita DU; Skards JV
Cor Vasa; 1990; 32(1):36-44. PubMed ID: 2340728
[TBL] [Abstract][Full Text] [Related]
4. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Z Kardiol; 1989; 78 Suppl 5():43-8. PubMed ID: 2561036
[TBL] [Abstract][Full Text] [Related]
5. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
8. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive therapy on plasma lipids and lipoproteins in mild hypertension.
Sagar S; Majumdar S; Sharma BK
Indian Heart J; 1989; 41(1):39-50. PubMed ID: 2737688
[TBL] [Abstract][Full Text] [Related]
10. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
[TBL] [Abstract][Full Text] [Related]
11. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
13. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
Klaus D
Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
[TBL] [Abstract][Full Text] [Related]
14. [The lipid peroxidation indices of hypertension patients undergoing combined therapy with anaprilin, korinfar and hypothiazide].
Iarema NI; Rudyk BI
Ter Arkh; 1995; 67(8):28-30. PubMed ID: 7482327
[TBL] [Abstract][Full Text] [Related]
15. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
16. Safety aspects of long-term antihypertensive therapy (10 years) with clonidine.
Ferder L; Inserra F; Medina F
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S104-8. PubMed ID: 2455159
[TBL] [Abstract][Full Text] [Related]
17. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
18. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
19. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
Manyemba J
Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
[TBL] [Abstract][Full Text] [Related]
20. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
Bagatin J; Rumboldt Z; Polić S; Sardelić S; Ljutić D; Capkun V; Pivac N; Petrović P; Bojić L
Lijec Vjesn; 1996; 118(1-2):11-6. PubMed ID: 8759414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
